Office Use Compounding

Office Use Compounding is a regulatory practice in pharmaceutical science that involves the preparation of customized medications by healthcare professionals for immediate administration to patients within a clinical setting, distinguished from other forms of compounding by its restriction to use within the practitioner’s office and exemption from standard manufacturing regulations under specified conditions.

2

Publications

55

Citations

6

Authors

1

Institutions

Publications per year

2017–2026

0

Authors

6

  1. AA
    Adnan A. Kadi

    King Saud University, Saudi Arabia

    1 publications · 26 citations

    1

    h-index

  2. WH
    William H. Soine

    Virginia Commonwealth University, United States

    1 publications · 26 citations

    1

    h-index

  3. CR
    Christine R. Birnie

    St. John Fisher College, United States

    1 publications · 29 citations

    1

    h-index

  4. DF
    Donna Francioni-Proffitt

    1 publications · 26 citations

    1

    h-index

  5. JG
    John G. Eley

    University of Maryland, Baltimore, United States

    1 publications · 29 citations

    1

    h-index

1–5 of 6

Institutions

1

  1. Palm Beach Atlantic University

    West Palm Beach, United States

    1 h-index

    1 publications

    29 citations

  2. Tufts University

    Medford, United States

    1 publications

    10 citations

1–2 of 1

Venues

  1. American Journal of Pharmaceutical Education

    2 publications · 55 citations

    2

    h-index

  2. BMJ

    1 publications · 10 citations

1–2